Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

ADVERTISEMENT

Nobel Prize in Medicine for COVID-19 vaccine  

This year’s Nobel Prize in Physiology or Medicine 2023 has been awarded jointly to Katalin Karikó and Drew Weissman “for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19”.  

Both Katalin Karikó and Drew Weissman are affiliated to University of Pennsylvania. Their contributions towards use of mRNA technologies for vaccine and therapeutic purposes have fundamentally changed understanding of how mRNA interacts with immune system and played a crucial role in development of vaccine against the COVID-19 pandemic at an unprecedented pace to meet the urgency.  

The key event was their observation that dendritic cells recognize in vitro transcribed mRNA as a foreign substance while mRNA from mammalian cells did not give rise to immune reaction. They investigated if the absence of altered bases in the in vitro transcribed RNA could be attributed to the unwanted inflammatory reaction and found that the inflammatory response was abolished when base modifications were included in the mRNA. This finding removed the key obstacle in use of mRNA technology for vaccine development and therapeutics and was published in 2005.  

Fifteen years later, the unprecedented situation presented by the COVID-19 pandemic led to fast-paced clinical trials and EUA of effective mRNA vaccines against the COVID-19. mRNA Vaccine against COVID-19 was a milestone in science and a game changer in medicine

Now, mRNA technology is proven technology for development of vaccines and therapeutics.  

Source:

NobelPrize.org. Press release – The Nobel Prize in Physiology or Medicine 2023. Posted 2 October 2023. Available at https://www.nobelprize.org/prizes/medicine/2023/press-release/   

***

SCIEU Team
SCIEU Teamhttps://www.ScientificEuropean.co.uk
Scientific European® | SCIEU.com | Significant advances in science. Impact on humankind. Inspiring minds.

Subscribe to our newsletter

To be updated with all the latest news, offers and special announcements.

Most Popular Articles

Particle colliders for study of “Very early universe”: Muon collider demonstrated

Particle accelerators are used as research tools for the...

Abell 2384: The New Twist in the Story of Merger of Two ‘Galaxy Clusters’

X-ray and radio observation of galaxy system Abell 2384...

Self-amplifying mRNAs (saRNAs): The Next Generation RNA Platform for Vaccines 

Unlike conventional mRNA vaccines which encodes only for the...
- Advertisement -
93,391FansLike
47,372FollowersFollow
1,772FollowersFollow
30SubscribersSubscribe